KK-125 OVARIAN CANCER RESEARCH FOUNDATION (EIN 464405177) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

KIMBERLY AUFILL

Phone

8062550403

Tax Period

2023-01-01 to 2023-12-31

KK-125 OVARIAN CANCER RESEARCH FOUNDATION, founded in 2013, is a micro nonprofit in the Diseases & Disorders sector that reported $232 in total revenue in fiscal year 2023. Revenue fell 69% from the prior year — a significant decline worth monitoring. Expenses of $2K exceeded revenue, resulting in a 901% operating deficit.

Mission

TO FOCUS ON REFORMING COMPASSIONATE USE, ADVANCING TREATMENTS AND CURES FOR OVARIAN CANCER, AND PROMOTING THE EARLY DETECTION OF OVARIAN CANCER THROUGH EDUCATION, RESEARCH AND AWARENESS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $232

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $232

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $473

Other Expenses $2,323

TOTAL EXPENSES $2,323

Year-over-Year Comparison

	2023	2022	Change
Revenue	$232	$755	-0.7%
Expenses	$2,323	$251	+8.3%
Net Income	$-2,091	$504	-5.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MICHELLE WITTENBURG	DIRECTOR/VP	8.00	Officer Director	$0	$0	$0
KIMBERLY AUFILL	DIRECTOR/SECRETARY	30.00	Officer Director	$0	$0	$0
JERRY KACAL	DIRECTOR/PRESIDENT	45.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$232	$2,323	$72,989	$-2,091
2022	$755	$251	$75,080	$504
2021	$3,359	$4,348	$74,576	$-989
2020	$3,557	$2,374	$75,565	$1,183
2019	$-10,077	$38,056	$74,385	$-48,133
2018	$5,400	$3,808	$120,374	$1,592

KK-125 OVARIAN CANCER RESEARCH FOUNDATION